Skip to main content
SpringerLink
Log in

DTaP-Hepatitis B-Poliovirus Vaccine (SmithKline Beecham)

InfanrixDTPa®-HepB-IPV

  • Section 2: Prophylactic Anti-Infective Vaccines
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yeh SH, Partridge S, Marcy SM, et al. A randomized study of the safety and immunogenicity of DTPa-HB-IPV vaccine administered as three doses or in a sequential IPV/OPVschedule at 2, 4, and 6 months of age. Pediatr Res 1998 Apr; 43 (Pt 2): 161

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

DTaP-Hepatitis B-Poliovirus Vaccine (SmithKline Beecham). Drugs R&D 2, 195–196 (1999). https://doi.org/10.2165/00126839-199902030-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199902030-00008

Keywords

Search

Navigation